OBJECTIVE: Health-related quality of life (HRQoL) in patients with systemic sclerosis (SSc), a chronic disabling disease associated to physical and psychological impairment, is often left behind in clinical practice and research. This is due to the use of tools that are not complete or mainly designed for the physical condition only. We tested EQ-5D, a valid, simple and brief questionnaire for HRQoL that has never been validated in SSc. METHODS: Thirty-three consecutive SSc patients referring to our Rheumatology Department and undergoing treatment have been asked to fulfill EQ-5D together with HAQ. RESULTS: EQ-5D demonstrated good acceptability, feasibility and validity in patients affected by SSc. Conceptually equivalent domains of EQ-5D demonstrated a good correlation with HAQ correspondent domains. CONCLUSIONS: We suggest the use of EQ-5D in SSc patients as a HRQoL measure in clinical practice, as well as an out come parameter in randomized clinical trials and/or in pharmaco-economic evaluations.

La valutazione della qualità della vita nei pazienti con sclerodermia=Health related quality of life assessment in patients with systemic sclerosis / R. Gualtierotti, L. Scalone, F.A. Ingegnoli, P. Cortesi, C. Lubatti, S. Zeni, P. Meroni. - In: REUMATISMO. - ISSN 0048-7449. - 62:3(2010 Sep), pp. 210-214. [10.4081/reumatismo.2010.210]

La valutazione della qualità della vita nei pazienti con sclerodermia=Health related quality of life assessment in patients with systemic sclerosis

R. Gualtierotti
Primo
;
L. Scalone
Secondo
;
F.A. Ingegnoli;C. Lubatti;P. Meroni
Ultimo
2010

Abstract

OBJECTIVE: Health-related quality of life (HRQoL) in patients with systemic sclerosis (SSc), a chronic disabling disease associated to physical and psychological impairment, is often left behind in clinical practice and research. This is due to the use of tools that are not complete or mainly designed for the physical condition only. We tested EQ-5D, a valid, simple and brief questionnaire for HRQoL that has never been validated in SSc. METHODS: Thirty-three consecutive SSc patients referring to our Rheumatology Department and undergoing treatment have been asked to fulfill EQ-5D together with HAQ. RESULTS: EQ-5D demonstrated good acceptability, feasibility and validity in patients affected by SSc. Conceptually equivalent domains of EQ-5D demonstrated a good correlation with HAQ correspondent domains. CONCLUSIONS: We suggest the use of EQ-5D in SSc patients as a HRQoL measure in clinical practice, as well as an out come parameter in randomized clinical trials and/or in pharmaco-economic evaluations.
Quality of Life ; Adult ; Aged ; Aged, 80 and over ; Awards and Prizes ; Feasibility Studies ; Female ; Humans ; Italy ; Male ; Middle Aged ; Outcome Assessment (Health Care) ; Patient Acceptance of Health Care ; Questionnaires ; Rheumatology ; Scleroderma, Systemic
Settore MED/16 - Reumatologia
set-2010
Article (author)
File in questo prodotto:
File Dimensione Formato  
483-942-1-SM.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 60.44 kB
Formato Adobe PDF
60.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/155993
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 16
  • ???jsp.display-item.citation.isi??? ND
social impact